Genesis Emerging

Director/PDMR Shareholding

RNS Number : 7280O
Genesis Emerging Markets Fund Ld
02 June 2020
 

Notification of transactions by Persons Discharging Managerial Responsibilities ('PDMRs') and persons closely associated with them

 

The company has been notified by the Director listed below of a transaction in the Company's Participating Preference Shares (the 'Shares'). 

 

This announcement is made in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr Simon Colson


2.

Reason for the notification

a)

Position/Status

Non-Executive Director  

b)

Initial Notification/

Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Genesis Emerging Markets Fund Limited

b)

LEI

213800HWWQPUJ4K1GS84

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Description   : Genesis Emerging Markets Fund Limited

Type   : Participating Preference Shares

ISIN  : GG00B4L0PD47

b)

Nature of Transaction

Purchase of Participating Preference Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 6.79

4,416

d)

Aggregated information



- Aggregated volume

 

- Price

Aggregate

Price(s)

Aggregate

Volume(s)

Aggregate

Total(s)

GBP 6.79

4,416

GBP 29,984.64

e)

Date of the transaction 

2 June 2020

f)

Place of the transaction

XLON

Name of authorised official of issuer responsible for making notification

 

J.P. Morgan Administration Services (Guernsey) Limited

Company Secretary

 

2 June 2020

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHKKBBDPBKDNAK